Clinical Trials for Patients With Cancer
This JAMA Oncology Patient Page explains clinical trials and what patients should consider regarding enrollment.
This JAMA Oncology Patient Page explains clinical trials and what patients should consider regarding enrollment.
The Lancet’s Breast Cancer Commission, published on April 15, 2024, predicts that by 2040, the global incidence of new cases of breast cancer will be…
Peruse the current issue of The Lancet Oncology, a monthly journal covering international issues relevant to clinical cancer specialists worldwide
James Ferrara, MD, DSc, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, introduces a system for the risk…
Instructions for Authors | JAMA | JAMA Network Instructions for Authors Contact Monica Mungle for help if edits are needed to the top section. Open…
This survey study assesses the ability of health care professionals to discern whether abstracts were written by investigators or by an artificial intelligence (AI) chatbot.
Tisotumab vedotin-tftv may now be given to patients with recurrent or metastatic cervical cancer, according to the FDA.
The European Commission has approved enzalutamide as monotherapy and in combination with ADT in BCR nonmetastatic hormone-sensitive prostate cancer.
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
The FDA has granted priority review to dostarlimab plus chemotherapy for all adult patients with primary advanced or recurrent endometrial cancer.
Background The autologous anti–B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy LCAR-B38M has been approved for the treatment of relapsed and refractory multiple…